COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention’s COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest rate since January 2022.
The Centers for Disease Control and Prevention recommended the updated 2024-2025 COVID-19 and flu vaccines for this fall and winter.
The Centers for Disease Control and Prevention recently urged nursing home residents to become vaccinated, following the release of research showing only 33% of residents were up to date with their COVID-19 vaccination.
The Food and Drug Administration this week authorized using a single dose of the Moderna or Pfizer bivalent COVID-19 vaccine for primary vaccination as well as for future doses.
The Centers for Disease Control and Prevention has added COVID-19 vaccines to the U.S. 2023 immunization schedules for adults and children.
The Department of Health and Human Services will launch a national advertising campaign and tour to encourage families to get the updated Pfizer or Moderna COVID-19 vaccine booster.
The Centers for Disease Control and Prevention (CDC) last week released guidance dropping its requirement for
White House health leaders stated this week the public likely will need annual COVID-19 booster shots,
The Food and Drug Administration (FDA) this week approved COVID-19 booster shots from Pfizer and Moderna targeting the omicron BA.4 and BA.5 subvariants
The Centers for Disease Control and Prevention (CDC) will resume control of COVID-19 hospital data collection in mid-December